Results 151 to 160 of about 17,078 (163)

Higher glycosylated hemoglobin levels increase the risk of overactive bladder syndrome in patients with type 2 diabetes mellitus

International Journal of Urology, 2012
Aih-Fung Chiu, Chung-Cheng Wang, Hann-Chorng Kuo   +2 more
exaly  

Down-Regulation of Nerve Growth Factor Expression in the Bladder by Antisense Oligonucleotides as New Treatment for Overactive Bladder

Journal of Urology, 2013
Mahendra Kashyap, Naoki Kawamorita, Vikas Tyagi   +2 more
exaly  

Systemic Nonurological Symptoms in Patients with Overactive Bladder

Journal of Urology, 2016
H Henry Lai, Joel Vetter, Sanjay Jain
exaly  

Prospective, Randomized, Double-Blind Study of the Efficacy and Tolerability of the Extended-Release Formulations of Oxybutynin and Tolterodine for Overactive Bladder: Results of the OPERA Trial

Mayo Clinic Proceedings, 2003
Ananias C Diokno, Rodney A Appell
exaly  

Overactive bladder revisited

Neurourology and Urodynamics, 2002
openaire   +2 more sources

Randomized Trial of Percutaneous Tibial Nerve Stimulation Versus Extended-Release Tolterodine: Results From the Overactive Bladder Innovative Therapy Trial

Journal of Urology, 2009
Kenneth M Peters, Scott A Macdiarmid, Eric S Rovner   +2 more
exaly  

Overactive Bladder

2019
Visha K. Tailor, G. Alessandro Digesu
openaire   +1 more source

Overactive Bladder

2018
Sanchia S. Goonewardene, Peter Pietrzak, David Albala   +2 more
openaire   +1 more source

Diabetes mellitus, systemic inflammation and overactive bladder

Frontiers in Endocrinology
Chengcheng Wei, Jun Wen, Jiatai He
exaly  

Overactive Bladder

2008
Kathryn L. Burgio, Dudley Robinson, Linda Cardozo   +2 more
openaire   +1 more source